Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9447405
Regulation of specific spinal neurons regulating pain transmission via chimeric toxins
granted -
US 9447401
PH20 polypeptide variants, formulations and uses thereof
granted -
US 9447390
Aldehyde tags, uses thereof in site-specific protein modification
granted -
US 9447376
Dried spore germinative compound mixtures
granted -
US 9447155
Isoform Nell-1 peptide
granted -
US 9447047
Inhibitors of protein phosphatase-1 and uses thereof
granted -
US 9446139
Polymer-based compositions and conjugates of HIV entry inhibitors
granted -
US 9446125
Anti-EphA2 antibodies and methods of use thereof
granted -
US 9447100
Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents
granted -
US 9446121
Cloning of honey bee allergen
granted -
US 9446112
Clostridium difficile DNA vaccine
granted -
US 9446107
Scaffolds for cell transplantation
granted -
US 9446068
Method of production of the stable selenium-comprising pharmaceutical composition with a high selenium level
granted -
US 9446072
Methods of ameliorating oxidative stress by increasing the efficiency of GPX and SOD activity
granted -
US 9446067
Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof
granted -
US 9446048
Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins
granted -
US 9446042
Pro-neurogenic compounds
granted -
US 9446037
Methods for the treatment of parkinson's disease psychosis using pimavanserin
granted -
US 9446038
Method and composition for treating a serotonin receptor-mediated condition
granted -
US 9446021
Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
granted -
US 9445870
Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye
granted -
US 9446022
Pro-neurogenic compounds
granted -
US 9446010
Compounds and methods for treating aberrant adrenocortical cell disorders
granted -
US 9446028
Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndrome
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.